Three-dimensionally Specific Inhibition of DNA Repair-Related Genes by Activated KRAS in Colon Crypt Model  by Tsunoda, Toshiyuki et al.
Three-dimensionally Specific
Inhibition of DNA Repair–Related
Genes by Activated KRAS in
Colon Crypt Model1,2
Toshiyuki Tsunoda*,†,3, Yasuo Takashima*,†,3,
Takahiro Fujimoto*,†, Midori Koyanagi*,†,
Yasuhiro Yoshida*, Keiko Doi*,†, Yoko Tanaka*,†,
Masahide Kuroki†, Takehiko Sasazuki‡
and Senji Shirasawa*,†
*Department of Cell Biology, Faculty of Medicine,
Fukuoka University, Fukuoka, Japan; †Center for Advanced
Molecular Medicine, Fukuoka University, Fukuoka, Japan;
‡International Medical Center of Japan, Tokyo, Japan
Abstract
Growth and differentiation of colonic epithelium are regulated in the three-dimensional (3D) physiological architecture,
colonic crypt, and deregulation of 3D interactions is involved in tumorigenesis. Cell-based 3D culture systems provide
a suitable approach bridging the gap between two-dimensional (2D) culture and animal models. KRAS mutations are
found at high frequencies in human colorectal cancer (CRC); however, KRAS-targeted cancer therapy has not been
developed. Here, we have established a 3D cell culture model resembling the colonic crypt by use of HKe3 cells,
human CRCHCT116 cells disrupted at activated KRAS. In this 3D colonic crypt model, HKe3 cells showed the features
of time course–dependent transit-amplifying and terminal-differentiated stages, which are characteristic of normal
colonic crypt. On the basis of the features of HCT116 cells, activated KRAS inhibited normal cell polarity and apoptosis
in 3D culture. The expression of DNA repair–related tumor suppressor genes including TP53, BRCA1, BRCA2, and
EXO-1wasmarkedly suppressed by activated KRAS in 3D culture but not in 2D culture. These results together suggest
that activated KRAS plays critical roles in the accumulation of genetic alterations through inhibition of DNA repair
genes and apoptosis and that this 3D culture model will provide a useful tool for investigating the molecular mecha-
nisms of CRC development.
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Introduction
Both cell-cell and cell-extracellular matrix interactions are critically
involved in developmental programs and provide three-dimensional
(3D) architectures in vivo [1], and deregulations of these interactions
are frequently observed in cancer [2]. Because cells grown in traditional
flat two-dimensional (2D) culture often differ in morphology, cell-cell
interactions, and differentiation from the cells grown in physiological
3D environments [3,4], cell-based in vitro 3D culture systems provide
a suitable approach that can bridge the gap between traditional 2D cell
culture and animal models [2,5]. Human cancers are derived from epi-
thelial tissues characterized by specific cellular architectures includ-
ing epithelial cell-cell junctions, which allow the separation of apical
and basolateral membranes. This apical-basal cell polarity is crucial in
normal cell functions, and loss of cell polarity is a critical step in tumori-
genesis [6–8].
Colonic epitheliummakes a 3D structure called colonic crypt, where
epithelial cells migrate upward through the transit-amplifying (TA)
zone in the lower-to-middle region of the crypt, before becoming termi-
nally differentiated (TD), and are eventually shed into the lumen [9].
Becausemost cell proliferation takes place in the TA region and terminal
differentiation occurs distal to this region [9], a 3D culturemodel resem-
bling colonic crypt should be needed for understanding the colorectal
tumorigenesis in vivo.
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Tumorigenesis is a multistep process in which genetic alterations accu-
mulate, culminating in neoplastic phenotype [10–12]. In the adenoma-
carcinoma sequencemodel of colorectal cancer (CRC) cell, adenomatous
polyposis coli gene mutations occur in the first step, followed by par-
ticular mutations of oncogenes and tumor suppressor genes, along with
genetic instability [11,13–15]. KRASmutations are frequently observed
not only in CRC but also in colorectal adenomas and in pancreatic and
lung cancers [16–18]. Oncogenic mutations in RAS are invariably point
mutations that either interfere with Ras GAP binding or directly dis-
rupt Ras GTPase activity, locking RAS in a constitutively active form
[16]. However, KRAS-targeted therapy has not been clinically devel-
oped, and patients with CRC bearing activated KRAS did not benefit
from cetuximab, a monoclonal antibody against the epidermal growth
factor receptor [17]. Elucidation of the precise molecular mechanisms
of activated KRAS in vivo should be needed for the design and devel-
opment of cancer therapies.
We and colleagues reported much about activated KRAS functions
through comparing human CRC HCT116 cells and HKe3 cells,
HCT116 cells disrupted at activated KRAS [19–22]. Here, we have es-
tablished in vitro a 3D culture model resembling colonic crypt using
HKe3 cells and elucidated the relation between activated KRAS and
3D architectures and functions comparing with HCT116 cells.
Materials and Methods
Cell Culture
2D culture for HCT116 cells, HKe3 cells, and e3-MKRas#14 cells
and for HKe3-derived stable transfectants expressing activated KRAS
was done as described previously [19,23]. A total of 5 × 105 cells were
cultured in 10-cm culture dishes (Nunc, Rochester, NY) [19]. For the
3D cell culture, 8 × 103 cells were cultured in LabTek 8-chamber slides
(Nunc) using Matrigel, a reconstituted basement membrane (BD Bio-
sciences, San Jose, CA), as described previously [24] and according to
the protocol online at http://brugge.med.harvard.edu/. Briefly, Matrigel
was thawed overnight at 4°C, and 25 μl per well was spread over the
surface of well on ice, followed by incubation at 37°C for 1 hour. Cells
were seeded in the medium containing 2% (vol/vol) Matrigel. Half of
the medium was replaced with fresh medium containing 2% Matrigel
every 3 days.
Immunofluorescence Labeling and Confocal Microscopy
Immunofluorescence experiment was done as described previously
[25]. Briefly, cells in the 3D culture were fixed using 3.7% formal-
dehyde in PBS and incubated at room temperature for 20 minutes.
Permeabilization was done using 0.05% saponin, and the fixed cells
were incubated at room temperature for 30 minutes. Blocking was
done by PBS containing 10% normal goat serum ( Jackson Immuno-
Research, West Grove, PA) at 4°C for 1 hour, followed by incubation
of primary antibodies in blocking buffer for 15 hours at 4°C. The wells
were washed three times with PBS containing 0.5% NP-40 and twice
with PBS, followed by incubation of Alexa-conjugated secondary anti-
bodies (Invitrogen, Carlsbad, CA) diluted in blocking buffer to 1:200
for 1 hour at room temperature. The wells were rinsed as described here,
and 50 μl of ProLong Gold antifade reagent (Invitrogen) was added.
Primary antibodies used were cleaved caspase-3 (5A1; Cell Signaling
Technology, Beverly, MA), laminin-5 (D4B5; Millipore, Billerica, MA),
ZO-1 (1/ZO-1; BD Biosciences, San Jose, CA), and Ki-67 (Thermo
Scientific, Rockford, IL). Alexa Fluor 568–conjugated to phalloidin
(Invitrogen) and 4′,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich,
St Louis, MO) were used for staining of F-actin and DNA, respectively.
For the examination of 3D structures, TCS-SP5 Laser Scanning confocal
microscopy (Leica, Wetzlar, Germany) was used. The figures show the
representative data from three independent experiments.
Quantification of Apoptosis in 3D Structures
HCT116 and HKe3 cells were cultured for 6 days in Matrigel and
were stained by anti–cleaved caspase-3 antibody and DAPI at day 6.
Cleaved caspase-3–positive cells were counted in a cross section of the
3Dculture atmaximumdiameter, and the 3D structure containingmore
than two positive cells were defined as apoptotic. The 3D structures for
HCT116 and HKe3 cells were analyzed in three independent experi-
ments, and the average ratio of apoptotic 3D structure was calculated.
Quantification of Proliferative Cells Grown in 3D Culture
HCT116 and HKe3 cells were cultured for 6 days in Matrigel and
were stained by anti–Ki-67 antibody and DAPI at the indicated day
from day 1 to day 6. The ratio of Ki-67–positive cells in the total cells
contacting Matrigel in the cross section of 3D structures at maximum
diameter was calculated. Similar results were obtained from indepen-
dent experiments.
Expression Microarray Analysis
Total RNA from cells cultured in the 2Dor 3D cultures were extracted
as described previously [26]. Gene expression arrays were done using
Human Genome U133 Plus 2.0 Array 6800 GeneChips (Affymetrix,
Santa Clara, CA) and were analyzed by GeneSpring v7.3 software
(Agilent Technologies, Santa Clara, CA) as previously described [26].
Real-time Quantitative Reverse Transcription–Polymerase
Chain Reaction
Real-time quantitative reverse transcription–polymerase chain reaction
was done by Perfect Real-time Support System (Takara Bio, Inc, Shiga,
Japan) for BRCA1 (HA113973), BRCA2 (HA119560), EXO1
(HA104791),TP53 (HA092869),CTNNB1 (HA115708), and ACTB
(HA067803). Complementary DNAwere synthesized from total RNA
as described previously [26]. Assays were performed on QuantiTect
SYBR Green PCR Kits (Qiagen, Valencia, CA) and ABI PRISM
7900HT (Applied Biosystems, Foster City, CA), and ACTB values were
used for normalization. The normalized values were quantified by the
ΔΔC t method and presented as means ± SDs for triplicate samples as
described previously [27,28]. Each relative expression unit (REU) was
determined by the REU of HCT116 in 2D culture as 1.0.
Western Blot Analysis
Western blot analysis was performed as described previously [29]. Cells
grown in 3D culture were harvested by cold PBSwith 5mMEDTA, and
Matrigel was separated by centrifugation, followed by cell lysis in RIPA
buffer. Lysates were spun at 12,000 rpm at 4°C for 10 minutes, and
the supernatants were quantified using Bradford ULTRA (Expedeon,
San Diego, CA). The antibodies used were p53 (DO-1; Santa Cruz
Biotechnology, Santa Cruz, CA) and ERK1 (K-23; Santa Cruz Bio-
technology). The figures show the representative blot from three inde-
pendent experiments. Quantitative Western blot analysis of p53 was
performed using a measurement module (BZ-H1M; Keyence, Osaka,
Japan) for obtaining integration values of each blot (n = 3). ERK1 in-
tensity was used as the standard. The relative intensity of each signal
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was normalized by the signal intensity in HKe3 cells grown in 3D
culture as 1.0.
Statistical Analysis
Data were presented as mean ± SDs of means of triplicate samples.
Statistical analysis was performed with an unpaired Student’s t-test to
compare the means of multiple groups. Differences at P < .05 are
considered to be statistically significant.
Results
HKe3 Cells in 3D Culture Showed Cell Polarity and Luminal
Cavity Formation
To elucidate the precise functions of activated KRAS in colorectal
tumorigenesis, we compared the 3D structures between HKe3 and
HCT116 cells grown in 3D cell culture using Matrigel containing
laminin and collagen. To address the KRAS functions in 3D culture,
morphological structure and apical-basal cell polarity were examined.
Firstly, we examined the distribution of laminin Vand F-actin, markers
for basement membrane and apical membrane, respectively, in the
HCT116 and HKe3 cells grown in 3D culture at day 6. Serial cross-
sectional images from bottom to top showed that HKe3 cells formed a
single layer of polarized cells and luminal cavity, where laminin V was
placed at the basal region and F-actin was localized in the apical region
(Figure 1A, from left to right). Conversely, localizations of laminin Vand
F-actin for HCT116 cells were disorganized, and luminal cavity was
not observed (Figure 1A), indicating the loss of apical-basal cell polarity
in HCT116 cells in the 3D culture. To further address cell polarity in
the 3D culture, we examined the distribution of ZO-1, a tight junc-
tion marker. ZO-1 signals were localized at the border between the
apical and basolateral membranes adjacent to luminal cavity of HKe3
cells but not in the HCT116 cells (Figure 1B), and distributions of
ZO-1 and F-actin were colocalized in the HKe3 cells in the 3D cul-
ture (Figure W1), suggestive of the existence of normal apical-basal
cell polarity in the HKe3 cells. Furthermore, e3-MKRas#14 cells,
HKe3-derived stable transfectants expressing activated KRAS [23],
showed impaired cell polarity or luminal cavity formation like HCT116
cells (Figure W2, A and B). These results together suggest that acti-
vated KRAS disturbs cell polarity and luminal cavity formation in
the 3D culture.
Apoptosis in Luminal Epithelium of HKe3 Cells
in 3D Structures
Apoptosis is induced by detaching from the surrounding extracellu-
lar matrix, called anoikis, in the luminal epithelial cells in vivo [30]. To
address whether activated KRAS influences apoptosis in the 3D culture,
we examined the apoptosis activity in the HCT116 and HKe3 cells
Figure 1. Activated KRAS is involved in loss of cell polarity, luminal cavity formation, and apoptosis. (A) Loss of apical-basal cell polarity
by activated KRAS. Serial cross-sectional (x-y plane) images of the 3D spherical structures were displayed in every 3-μm distance (z axis).
Red, F-actin; blue, nuclear DNA; green, laminin V. Bar, 25 μm. (B) Disruption of tight junctions by activated KRAS. Arrowhead indicates
the ZO-1 signal. Blue, nuclear DNA; green, ZO-1. Bar, 50 μm. (C) Inhibition of apoptosis by activated KRAS. HCT116 and HKe3 cells in the
3D structures at day 6 were stained with DAPI (blue) and antibodies to the cleaved caspase-3 (green; left). Arrowhead indicates the cleaved
caspase-3 signal. DAPI, blue; cleaved caspase-3, green. Bar, 50 μm. The ratio of the apoptotic 3D structures was shown (right). White bar,
HCT116; black bar, HKe3. *P < .001.
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by detecting the cleaved caspase-3 signals. The ratios of apoptotic 3D
structures for HCT116 and HKe3 cells were 16.9% and 80.5%, re-
spectively (*P < .001; Figure 1C), indicating that apoptosis activity is
present for luminal cavity epithelium in the 3D culture of HKe3 cells
and is inhibited in the HCT116 cells. Furthermore, apoptosis activity
in e3-MKRas#14 cells was inhibited like HCT116 cells (Figure W2C).
These results suggest that activated KRAS suppresses apoptosis in the
3D culture.
HKe3 Cells in the 3D Culture as a Colonic Crypt Model
Continuous proliferation is one of the features of cancer cells in the
traditional 2D culture. A proliferation marker Ki-67 signal for HKe3
cells grown in 2D culture was expectedly detected only in the cells
located at the outer region but not at the inner region (Figure 2A). Con-
versely, the Ki-67 signal for the HCT116 cells grown in 2D culture was
observed in both the inner and outer regions (Figure 2A). Together,
these results suggest that activated KRAS suppresses the contact inhibi-
tion of cell growth in the 2D culture.
To address whether or how activated KRAS influences cell prolifera-
tion in the 3D cell culture, we examined the time course–dependent
proliferation of the cells grown in the 3D culture for 6 days. Ki-67
signals were evidently detected both in the HKe3 and HCT116 3D
structures from day 1 to day 3, whereas Ki-67 signals were suddenly de-
creased at day 4 not only in the HKe3 cells but also in the HCT116
cells (Figure 2B). Ki-67–positive cells in the 3D structures of HCT116
and HKe3 were similarly decreased time course–dependently, 97.1%
and 97.6% at day 2, 80.8% and 91.9% at day 3, 64.7% and 54.6% at
day 4, 34.4% and 51.2% at day 5, and 11.0% and 11.8% at day 6,
respectively (Figure 2C ). A significant difference in the ratio of Ki-67–
positive cells between theHCT116 andHKe3 cells was not detected at
any time point (P > .05; Figure 2C ). These results, together, suggest
that activated KRAS is rather involved in the inhibition of apoptosis
than in cell proliferation. Of note is the decreased proliferation and
luminal cavity formation in HKe3 cells in the 3D culture at day 4,
as TA cells in the colonic crypt in vivo differentiate to TD cells at
day 4 [9], suggesting that HKe3 cells in this 3D culture will be applied
as a colonic crypt model.
Figure 2. Cell proliferation detected by Ki-67 in the 2D and 3D cultures. (A) Ki-67 signals in HCT116 or HKe3 cells at day 6 in the 2D
culture. Green, Ki-67; blue, nuclear DNA (DAPI). Bar, 50 μm. (B) Ki-67 signals in HCT116 or HKe3 cells at the indicated day from day 1 to day 6
in the 3D culture. Bright field image is also shown. Green, Ki-67; blue, nuclear DNA (DAPI). Bar, 50 μm. (C) The ratio of Ki-67–positive cells at
the indicated day from day 1 to day 6 the in 3D culture. Blue circle, HCT116; purple rectangle, HKe3.
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3D-Specific Suppression of DNA Metabolism–Related Genes
by Activated KRAS
To explore the differentially expressed genes regulated by activated
KRAS in the 3D culture, we performed expression microarrays using
HCT116 and HKe3 cells grown in the 2D or 3D culture for 6 days.
Differentially expressed genes were cut off by three-fold up or three-
fold down, and these are shown as a Venn diagram (Figure 3A), and
the genes detected are listed (Tables W1–W3). Of note is the exis-
tence of 3D-specific differentially expressed genes. The numbers of
3D-specific three-fold up- and three-fold down-expressed genes were
328 and 1397, respectively (Figure 3A; Table W4).
To address the functions of 3D-specific downregulated genes by
activated KRAS, we performed gene ontology (GO) analysis for the
genes (Table W4). The significant GO for the 3D-specific down-
regulated genes by activated KRAS was classified into the GOs such
as “DNA metabolism” (with a P value of 7.6e−24), “DNA repair” (P =
1.4e−19), “response to DNA damage stimulus” (P = 3.8e−18), and
“cell cycle checkpoint” (P = 1.9e−16; Table W4B). However, the most
significant GO for the 3D-specific upregulated genes by activated
KRAS was “entrainment of circadian clock” with a P value of 1.1e−4
(data not shown). From the viewpoint of tumorigenesis and statistical
significance, 3D-specific downregulated genes by activated KRAS are
of great interest. The 3D-specific downregulated genes, including
BRCA1 [12,31–35], BRCA2 [12,31,33,34,36,37], EXO1 (exonuclease-1)
[38–40], and TP53 (p53) [12,34,41,42], were commonly listed
among the GO categories related to “DNA metabolism,” “cell cycle,”
“DNA repair,” and “response to DNA damage stimulus” (Table W4C),
and these four genes are known as tumor suppressor genes [1,33,38].
Interestingly, in the 2D culture, expressions of these four genes in
HCT116 cells, compared with those in HKe3 cells, were 4.15-,
4.27-, 4.60- and 1.19-fold upregulated, respectively (Table W4, A
and D). Furthermore, 62 of the 3D-specific downregulated 72 genes
classified as “DNA metabolism” were rather upregulated in the 2D
culture, indicating the opposite expression profiles for these genes be-
tween 2D and 3D cultures (Table W4D).
3D-Specific Suppression of TP53, BRCA1, BRCA2 and EXO-1
by Activated KRAS
Weperformed real-time quantitative reverse transcription–polymerase
chain reaction to validate the microarray results of BRCA1, BRCA2,
EXO-1, and TP53. In HKe3 cells for the 3D culture, the expression
levels of BRCA1, BRCA2, EXO-1, and TP53 were increased to 11.22,
6.38, 6.20, and 9.31 times, respectively (*P < .001) compared with
HCT116 cells in the 3D culture (Figure 3B), suggesting that activated
KRAS in the 3D culture exactly inhibits the messenger RNA (mRNA)
expressions of these four genes. In the 2D culture, the expression levels
of BRCA1, BRCA2, and EXO-1 in HKe3 cells, compared with those in
HCT116 cells, were decreased to 0.21, 0.28, and 0.28 times, respec-
tively (P < .001), whereas TP53 was not significantly changed in the
2D culture (1.09 times, P = .31; Figure 3B).
Figure 3. 3D-specific suppression of DNA repair–related tumor sup-
pressorgenes including TP53,BRCA1,BRCA2, andEXO-1byactivated
KRAS. (A) Differentially expressed genes detected by the expres-
sionmicroarray analysis. Venn diagrams show the number of genes
more than three-fold down (gray circles) or three-fold up (white
circles) in HCT116 cells compared with HKe3 cells in the 2D culture
(2DC) and/or the 3D culture (3DC). (B) Validation of mRNA expres-
sion levels of the 3D-specific downregulated genes detected by
microarray expression analysis. Each REUwas normalized to ACTB,
and REUswere determined by the REU of HCT116 in the 2D culture
as 1.0. Statistical significance (*P < .001) exists in REUs between
HCT116 in the 2D culture and HKe3 in the 3D culture. n.s., no signi-
ficant difference. CTNNB1 as control. Gray bar, HCT116 in the 2D
culture; light gray bar, HKe3 in the 2D culture; black bar, HCT116
in the 3D culture;white bar, HKe3 in the 3D culture. (C)Western blot
analysis of p53 in HCT116 and HKe3 cells in the 2D or 3D culture
(upper). Quantitative analysis for the expression of p53 (lower). Each
signal was normalized to ERK1. Relative intensities of p53 were
determined by the p53 signal of HKe3 cells in the 3D culture as
1.0. *P< .05, **P< .005, ***P< .0005. n.s., no significant difference.
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These four gene expressions in HCT116 cells in the 3D culture,
compared with those in the 2D culture, were decreased to 0.05
(BRCA1), 0.05 (BRCA2), 0.09 (EXO1), and 0.04 (TP53) times, re-
spectively (P < .001), whereas these gene expressions in HKe3 cells
in the 3D culture, compared with those in the 2D culture, were in-
creased to 8.11 (BRCA1), 3.84 (BRCA2), 2.03 (EXO-1), and 1.28
(TP53) times, respectively (P < .05). Together, these results suggest
the critical roles for activated KRAS in the regulation of expression of
these tumor suppressor genes.
Considering the importance of p53 in tumorigenesis, we examined
p53 protein level by Western blot. Although the p53 protein level
in HCT116 cells in the 2D culture, compared with HKe3 cells in
the 2D culture, was slightly increased to 1.23 times (**P < .005),
p53 protein level in HCT116 cells in the 3D culture, compared with
HKe3 cells in the 3D culture, was decreased to 0.75 times (*P < .05;
Figure 3C ). Furthermore, p53 expression in HKe3 cells in the 3D
culture, compared with that in the 2D culture, was increased to 1.43
times (***P < .0001; Figure 3C ). Together, these results suggest that
the p53 protein level is increased in the 3D culture through loss of
activated KRAS.
Discussion
HKe3 cells, human CRC HCT116 cells disrupted at activated KRAS,
formed a colonic cryptlike 3D structure and showed time course–
dependent proliferation and differentiation under the 3D micro-
environment (Figure 4A). In the 3D cell culture for HKe3 cells,
HKe3 cells divided like TA cells in the colonic crypt from day 1 to
day 3 and displayed the polarized structures like TD cells after day 4,
followed by apoptosis in luminal epithelium (Figures 1 and 4A). In
contrast, HCT116 cells having activated KRAS and HKe3-derived
e3-MKRas#14 cells expressing activated KRAS lost apical-basal cell
polarity and apoptosis/anoikis (Figures 1 and 4B; Figure W2). After
day 4, proliferative cells detected by Ki-67 signals were evidently de-
creased both in HCT116 and in HKe3 cells (Figure 2, B and C ). All
these results suggest that HKe3 cells in the 3D culture show the features
of colonic crypt, and this 3D cell culture system will be useful for eluci-
dating the molecular mechanisms of CRC and novel functions for
activated KRAS in vivo.
From the viewpoint of the regulated genes by activated KRAS, DNA
repair–related tumor suppressor genes, including TP53 [1,12,34,42],
BRCA1 [12,31–35], BRCA2 [12,31,33,34,36,37], and EXO-1 [38–
40], were downregulated in a 3D-specific manner, suggesting that
activated KRAS plays critical roles in the accumulation of genetic altera-
tions through the suppression of DNA repair genes (Figure 4B), and
this suppression leads to the disruption of a barrier to tumor progres-
sion in precancerous lesions [43].
Because colonic crypts in vivo are localized in an acidic micro-
environment and are continuously exposed to oxidative stress, colonic
crypt cells possess higher DNA repair activity [44,45]. Cells grown in
the 3D culture here might reflect microenvironment in vivo to react
against acidic condition, culminating in an induced expression of
DNA repair genes and activated KRAS might inhibit DNA repair ac-
tivity, leading to the accumulation of genetic alterations. The reason
why DNA repair activity is remarkable in the 3D culture, but not in
the 2D culture, may reflect the difference between cellular conditions
induced bymicroenvironments of the 2Dand 3D cultures. Thus,micro-
environmental conditions should be much taken into account for
elucidating molecular mechanisms of cancer. In this study, we focused
on interactions of epithelial cells and basement membranes in the 3D
microenvironment; therefore, evaluation of other microenvironmental
conditions including stroma cells should be needed for a better under-
standing of molecular mechanisms underlying the development of
CRC in vivo.
The down-regulation of DNA repair–related tumor suppressor
genes was evidently detected at the mRNA level (Figure 3B), whereas
the p53 protein level was not completely concomitant with the mRNA
level (Figure 3C), suggesting that particular mechanisms do exist in the
regulation of p53, such as protein degradation and translation regulated
by microRNA [46]. Further examination of the differentially expressed
Figure 4. Critical function of activated KRAS in DNA repair–related
tumor suppressor genes in the 3D colonic crypt model. (A) A sche-
matic model of HKe3 cells in the 3D culture as colonic crypt in vivo.
A representativemodel is shown at day 3 and day 6when TA and TD
cells mainly exist, respectively. Apoptotic cells are produced from
TD cells in the luminal cavity. Red, apoptotic cell; green, proliferating
cells; blue, differentiated cells. (B) A schematic model of apoptosis
and proliferation in the colonic crypt and activated KRAS function in
the inhibition of DNA repair–related tumor suppressor genes. Apop-
tosis and proliferation indexes are shown for HKe3 (red and black
lines) and HCT116 (green and blue lines) cells. “T” sign indicates
the repression of DNA repair–related tumor suppressor genes in-
cluding TP53, BRCA1, BRCA2, and EXO-1 by activated KRAS.
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genes including microRNA and signaling on this 3D culture system
will lead to a better understanding of CRC development.
Another issue in this study is that the molecular mechanisms of
tumorigenesis should be reevaluated in the 3D microenvironment
[2]. Most of the downregulated genes classified as “DNA metabolism”
by activated KRAS in the 3D culture were rather upregulated in the 2D
culture, i.e., opposite expression profiles between the 2D and 3D cul-
tures exist (Table W4D). Researchers should adequately consider cell
culture conditions; otherwise, molecular mechanisms of the tumori-
genesis in vivo may be misunderstood.
We have established a 3D colonic crypt model using HKe3 cells,
HCT116 cells disrupted at activated KRAS, and demonstrated that
activated KRAS is involved in deregulation of apical-basal cell polar-
ity, luminal cavity formation with apoptosis, and 3D-specific sup-
pression of DNA repair–related tumor suppressor genes including
TP53, BRCA1, BRCA2, and EXO-1. Activated KRAS plays critical
roles in the accumulation of genetic alterations through the inhibi-
tion of DNA repair genes and apoptosis, resulting in the disruption
of the barrier-to-tumor progression. Our 3D colonic crypt model will
provide a useful tool for investigating the molecular mechanisms of
CRC development in vivo and design of CRC therapies.
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Figure W1. Apical-basal cell polarity in HKe3 cells. Green, ZO-1; red,
F-actin. Bar, 25 μm.
Figure W2. Loss of cell polarity, luminal cavity formation, and apoptosis in e3-mKRas#14 cells. (A) Loss of apical-basal cell polarity in
e3-MKRas#14 cells. Serial cross-sectional (x-y plane) images of 3D spherical structures were displayed in every 3-μm distance (z axis).
Red, F-actin; blue, nuclear DNA; green, laminin V. Bar, 25 μm. (B) Disruption of tight junctions in e3-MKRas#14 cells. Blue, nuclear DNA;
green, ZO-1. Bar, 50 μm. (C) Inhibition of apoptosis in e3-MKRas#14 cells. e3-MKRas#14 cells in the 3D structures at day 6were stainedwith
DAPI (blue) and antibodies to the cleaved caspase-3 (green) (left). Blue, nuclear DNA; green, cleaved caspase-3. Bar, 50 μm.
